Sustained elevated levels of circulating vasopressin selectively stimulate the proliferation of kidney tubular cells via the activation of V2 receptors

Endocrinology

Volumn 150, Issue 1, 2009, Pages 239-250

  Alonso, Gérard ^a,b,c   Galibert, Evelyne ^a,b,c   Boulay, Véra ^a,b,c   Guillou, Anne ^a,b,c   Jean, Alexandra ^a,b,c   Compan, Valérie ^a,b,c   Guillon, Gilles ^a,b,c  

^a INSTITUT DE GÉNOMIQUE FONCTIONNELLE   (France)

^b CNRS   (France)

^c UNIV MONTPELLIER   (France)

Author keywords

[No Author keywords available]

Indexed keywords

HYPOTHALAMUS HORMONE; MITOGEN ACTIVATED PROTEIN KINASE; RECEPTOR SUBTYPE; VASOPRESSIN; VASOPRESSIN RECEPTOR ANTAGONIST; VASOPRESSIN V1B RECEPTOR; VASOPRESSIN V2 RECEPTOR;

ADRENAL GLAND; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL STIMULATION; CELL SUBPOPULATION; CELL TYPE; HORMONE BLOOD LEVEL; HORMONE RELEASE; KIDNEY; KIDNEY TUBULE CELL; LIVER; MALE; MITOGENESIS; NONHUMAN; OSMOTIC MINIPUMP; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RAT; RECEPTOR INTRINSIC ACTIVITY;

ANIMALS; ARGININE VASOPRESSIN; CELL DIVISION; DEAMINO ARGININE VASOPRESSIN; KIDNEY TUBULES; MALE; OSMOLAR CONCENTRATION; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, VASOPRESSIN; SODIUM CHLORIDE;

EID: 58149460380     PISSN: 00137227     EISSN: 00137227     Source Type: Journal    
DOI: 10.1210/en.2008-0068     Document Type: Article

References (55)

1. Bankir L, Bouby N, Trinh-Trang-Tan MM 1991 Vasopressin-dependent kidney hypertrophy: role of urinary concentration in protein-induced hypertrophy and in the progression of chronic renal failure. Am J Kidney Dis 17:661-665
2. Nemenoff RA 1998 Vasopressin signaling pathways in vascular smooth muscle. Front Biosci 3:d194-d207
3. Antoni FA 1993 Vasopressinergic control of pituitary adrenocorticotropin secretion comes of age. Front Neuroendocrinol 14:76-122
4. Shimazaki T, Iijima M, Chaki S 2006 The pituitary mediates the anxiolytic-like effects of the vasopressin V1B receptor antagonist, SSR149415, in a social interaction test in rats. Eur J Pharmacol 543:63-67
5. Yang XD, Zhao LY, Zheng QS, Li X 2003 Effects of arginine vasopressin on growth of rat cardiac fibroblasts: role of VI receptor. J Cardiovasc Pharmacol 42:132-135
6. Chiu T, Wu SS, Santiskulvong C, Tangkijvanich P, Yee Jr HF, Rozengurt E 2002 Vasopressin -mediated rnitogenic signaling in intestinal epithelial cells. Am J Physiol Cell Physiol 282:C434-C450
7. Gallo-Payet N, Guillon G 1998 Regulation of adrenocortical function by vasopressin. Horm Metab Res 30:360-367
8. Bhora FY, Kothary PC, Imanishi H, Eckhauser FE, Raper SE 1994 Vasopressin stimulates DNA synthesis in cultured rat hepatocytes. J Surg Res 57:706-710
9. Ganz MB, Pekar SK, Perfetto MC, Sterzel RB 1988 Arginine vasopressin promotes growth of rat glomerular mesangial cells in culture. Am J Physiol 255: F898-F906
10. Meinders AE 1985 Current concept of the role of antidiuretic hormone in osmoregulation and volume regulation in man. A review. Neth J Med 28:401-407
11. Robertson GL 2006 Regulation of arginine vasopressin in the syndrome of inappropriate antidiuresis. Am J Med 119:S36-S42
12. Baylis PH 2003 The syndrome of inappropriate antidiuretic hormone secretion, lnt J Biochem Cell Biol 35:1495-1499
13. Horky K, Sramkova J, Lachmanova J, Tomasek R, Dvorakova J 1979 Plasma concentration of antidiuretic hormone in patients with chronic renal insufficiency on maintenance dialysis. Horm Metab Res 11:241-246
14. Bald M, Gross P, Rascher W 1991 Elevated plasma concentration of argininevasopressin in renal insufficiency is not caused by nonspecific binding of metabolic breakdown products. Nephron 59:520-521
15. Gross P, Rascher W 1986 Vasopressin and hyponatremia in renal insufficiency. Contrib Nephrol 50:54-63
16. Zerbe RL, Vinicor F, Robertson GL 1979 Plasma vasopressin in uncontrolled diabetes mellitus. Diabetes 28:503-508
17. Zerbe RL, Vinicor F, Robertson GL 1985 Regulation of plasma vasopressin in insulin-dependent diabetes mellitus. Am J Physiol 249:E317-E325
18. van Londen L, Kerkhof GA, van den Berg F, Goekoop JG ZKH, Frankhuijzen-Sierevogel AC, Wiegant VM, de Wied D 1998 Plasma arginine vasopressin and motor activity in major depression. Biol Psychiatry 43:196-204
19. van Londen L, Goekoop JG, van Kempen GM 1997 Plasma levels of arginine vasopressin elevated in patients with major depression. Neuropsychopharmacology 17:284-292
20. Jard S, Gaillard RC, Guillon G, Marie J SP, Muller AF, Manning M, Sawyer WH 1986 Vasopressin antagonists allow demonstration of a novel type of vasopressin receptor in the rat adenohpophysis. Mol Pharmacol 30:171-177
21. Grazzini E, Boccara G, Joubert D 1998 Vasopressin regulates adrenal functions by acting through different vasopressin receptor subtypes. Adv Exp Med Biol 449:325-334
22. Howl J, Ismail T, Strain AJ, Kirk CJ, Anderson D, Wheatley M 1991 Characterization of the human liver vasopressin receptor. Profound differences between human and rat vas opressin-receptor-media ted responses suggest only a minor role for vasopressin in regulating human hepatic function. Biochem J 276{Pt 1):189-195
23. Bankir L 2001 Antidiuretic action of vasopressin: quantitative aspects and interaction between Via and V2 receptor-mediated effects. Cardiovasc Res 51:372-390
24. Lolait SJ, O'Carroll AM, Malian LC, Felder CC HD, Young 3rd WS, Mezey E, Brownstein MJ 1995 Extrapituitary expression of the rat Vlb vasopressin receptor gene. Proc Natl Acad Sci USA 92:6783-6787
25. Pena A, Murat B, Trueba M, Ventura MAB, Cheng G, Stoev LL, Szeto S, Wo HH, Brossard N, Serradeil-Le Gal G, Manning C, Guillon MG 2007 Pharmacological and physiological characterization of d[Leu4, Lys8] vas opressin, the first Vlb-selective agonist for rat vasopressin/oxytocin receptors. Endocrinology 148:4136-4146
26. Paterson JA, Leblond CP 1977 Increased proliferation of neuroglia and endothelial cells in the supraoptic nucleus and hypophysial neural lobe of young rats drinking hypertonic sodium chloride solution. J Comp Neurol 175:373-390
27. Zhang Z, Cai Q, Michea L, Dmitrieva NI, Andrews P, Burg MB 2002 Proliferation and osmotic tolerance of renal inner medullary epithelial cells in vivo and in cell culture. Am J Physiol Renal Physiol 283:F302-F308
28. Dmitrieva NI, Burg MB 2005 Hypertonic stress response. Mutat Res 569: 65-74
29. Imbert-Teboul M, Champigneulle A 1995 [Functional expression of vasopressin receptors V1a and V2 along the mammalian nephron]. C R Seances Soc Biol Fil 189:151-167
30. Saito M, Tahara A, Sugimoto T, Abe K, Furuichi K 2000 Evidence that atypical vasopressin V(2) receptor in inner medulla of kidney is V(1B) receptor. Eur J Pharmacol 401:289-296
31. Marples D, Knepper MA, Christensen El, Nielsen S 1995 Redistribution of aquaporin-2 water channels induced by vasopressin in rat kidney inner medullary collecting duct. Am J Physiol 269:C655-C664
32. Holthofer H, Kumpulainen T, Rapola J 1990 Polycystic disease of the kidney. Evaluation and classification based on nephron segment and cell-type specific markers. Lab Invest 62:363-369
33. Boulton TG, Nye SH, Robbins DJ, Ip NY, Radziejewska E, Morgenbesser SD, DePinho RA, Panayotatos N, Cobb MH, Yancopoulos GD 1991 ERKs: a family of protein-serin e/threonine kinases that are activated and tyrosine phosphorylated in response to insulin and NGF. Cell 65:663-675
34. Rubin H 2002 The disparity between human cell senescence in vitro and lifelong replication in vivo. Nat Biotechnol 20:675-681
35. Rose JrCE, Rose KY,Kinter LB 1991 Effect of Vl/V2-receptor antagonism on renal function and response to vasopressin in conscious dogs. Am J Physiol 260:F273-F282
36. Barthelmebs M, Krieger JP, Grima M, Nisato D, Imbs JL 1996 Vascular effects of [Arg8] vas opressin in the isolated perfused rat kidney. Eur J Pharmacol 314:325-332
37. Loichot C, Cazaubon C, De Jong W, Helwig JJ ND, Imbs JL, Barthelmebs M 2000 Nitric oxide, but not vasopressin V2 receptor-mediated vasodilation, modulates vas opressin-induced renal va so constriction in rats. Naunyn Schmiedebergs Arch Pharmacol 361:319-326
38. Thibonnier M, Conarty DM, Plesnicher CL 2000 Mediators of the mitogenic action of human V(1) vascular vasopressin receptors. Am J Physiol Heart Circ Physiol 279:H2529-H2539
39. Breyer MD, Ando Y 1994 Hormonal signaling and regulation of salt and water transport in the collecting duct. Annu Rev Physiol 56:711-739
40. Dumaz N, Marais R 2005 Integrating signals between cAMP and the RAS/RAF/MEK/ERK signalling pathways. Based on the anniversary prize of the Gesellschaft fur Biochemie und Molekularbiologie Lecture delivered on 5 July 2003 at the Special FEBS Meeting in Brussels. FEBS J 272:3491-3504
41. Yamaguchi T, Nagao S, Wallace DP, Belibi FA, Crowley BD, Pelling JC, Grantham JJ 2003 Cyclic AMP activates B-Raf and ERK in cyst epithelial cells from autosomal-dominant polycystic kidneys. Kidney lnt 63:1983-1994
42. Yamaguchi T, Hempson SJ, Reif GA, Hedge AM, Wallace DP 2006 Calcium restores a normal proliferation phenotype in human polycystic kidney disease epithelial cells. J Am Soc Nephrol 17:178-187
43. Yamaguchi T, Wallace DP, Magenheimer BS, Hempson SJ, Grantham JJ, Calvet JP 2004 Calcium restriction allows cAMP activation of the B-Raf/ERK pathway, switching cells to a cAMP-dependent growth-stimulated phenotype. J Biol Chem 279:40419-40430
44. Culpepper RM, Andreoli TE 1983 Interactions among prostaglandin E2, antidiuretic hormone, and cyclic adenosine monophosphate in modulating Cl-absorption in single mouse medullary thick ascending limbs of Henle. J Clin Invest 71:1588-1601
45. Torikai S, Kurokawa K 1983 Effect of PGE2 on vasopressin-dependent cell cAMP in isolated single nephron segments. Am J Physiol 245:F58-F66
46. Orellana SA, Avner ED 1995 Cystic maldevelopment of the kidney. Semin Nephrol 15:341-352
47. Nadasdy T, Laszik Z, Lajoie G, Blick KE, Wheeler DE, Silva FG 1995 Proliferative activity of cyst epithelium in human renal cystic diseases. J Am Soc Nephrol 5:1462-1468
48. Danielsen H, Nielsen AH, Pedersen EB, Herlevsen P, Kornerup HJ, Posborg V 1986 Exaggerated natriuresis in adult polycystic kidney disease. Acta Med Scand 219:59-66
49. Gattone 2nd VH, Wang X, Harris PC, Torres VE 2003 Inhibition of renal cystic disease development and progression by a vasopressin V2 receptor antagonist. Nat Med 9:1323-1326
50. Wang X, Gattone 2nd V, Harris PC, Torres VE 2005 Effectiveness of vasopressin V2 receptor antagonists OPC-31260 and OPC-41061 on polycystic kidney disease development in the PCK rat. J Am Soc Nephrol 16:846-851
51. Wang X, Wu Y, Ward CJ, Harm PC, Torres VE 2008 Vasopressin directly regulates cyst growth in polycystic kidney disease. J Am Soc Nephrol 19:102-108
52. Nagao S, Nishii K, Katsuyama M 2006 Increased water intake decreases progression of polycystic kidney disease in the PCK rat. J Am Soc Nephrol 17: 2220-2227
53. Thomson RB, Mentone S, Kim R, Earle K DE, Somlo S, Aronson PS 2003 Histopathological analysis of renal cystic epithelia in the Pkd2WS25/- mouse model of ADPKD. Am J Physiol Renal Physiol 285:F870-F880
54. Kriz W, Bankir L 1982 ADH-induced changes in the epithelium of the thick ascending limb in Brattleboro rats with hereditary hypothalamic diabetes insipidus. Ann NY Acad Sci 394:424-434
55. Bouby N, Bankir L, Trinh-Trang-Tan MM, Minutli WW, Kriz W 1985 Selective ADH-induced hypertrophy of the medullary thick ascending limb in Brattleboro rats. Kidney Int 28:456-466